Sabra Health Care CEO Richard K. Matros Sells $4.17 Million in Stock

Sabra Health Care REIT, Inc. Chair, CEO, and President Richard K. Matros sold 200,000 shares of company stock on September 8, 2026, for a total value of approximately $4.17 million. The transaction occurred via a pre-established Rule 10b5-1 trading plan, which is a mechanism corporate insiders use to manage equity holdings while maintaining regulatory compliance.

"The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Matros on June 8, 2026," according to an industry report.

Transaction Details and Holdings

The shares were sold at prices ranging from $20.66 to $20.94. After this transaction, Matros retains an equity position in the REIT. He currently holds 956,268 stock units directly and maintains an indirect interest in 1,657,686 shares held through the R&A Matros Revocable Trust.

Understanding Rule 10b5-1 Plans

Corporate insiders like CEOs and board members are often privy to material, non-public information that could influence a company's stock price. To avoid legal concerns regarding insider trading, executives use Rule 10b5-1 plans to schedule sales or purchases in advance.

By adopting a plan when they are not in possession of sensitive information, executives set specific parameters, such as dates, price floors, or volume limits, for future transactions. Once the plan is established, the trading occurs automatically. This removes the executive's discretion over the timing of individual trades and provides a defense against potential allegations of market manipulation.